dsm-firmenich
About dsm-firmenich
Certifications
Categories
-
CH
-
2015On CPHI since
-
1Certificates
-
5000+Employees
Company types
Primary activities
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Products from dsm-firmenich (5)
-
Product Functional ingredients
Bioavailability enhancers Our drug facilitators target and enhance bioavailability to help support the activity of your active ingredients. Antioxidants Our antioxidants can be used to improve the stability of your pharmaceutical formulation. In addition, due to their role in suppressing nitrosamine fo... -
Product Intermediates
When you partner with DSM, you get access to our portfolio of high-quality lipids. We have a strong legacy of trust in the production and global commercialization of EPA and DHA derived from sustainable marine sources and microbial fermentation. This, backed by our capabilities to offer customized lipid in... -
Product Active Pharmaceutical Ingredients (vitamins, cannabinoids, carotenoids)
Vitamins When you partner with DSM, you get the broadest portfolio of proven, safe and innovative vitamin actives on the market. We are the first and only company in the world that can provide access to the US and Japanese Drug Master Files (DMFs) and the Certificates of Suitability (CEPs) for all 13 vita... -
Product Cannabinoid actives / CBD APIs
Our CBD API has 0% THC or other impurities in line with ICH guidelines and no pesticides, herbicides, or heavy metals. It has been tested by a World Anti-Doping Agency (WADA) lab, NSF and Informed Choice, confirmed for the absence of THC and banned substances. The product follows ICH Q7 regulations and is ... -
Product Cannabinoid APIs (CBD)
The cannabinoid-based drug market is growing rapidly. To facilitate early-stage drug development in this emerging field of research, DSM has created an innovation platform, in partnership with Brains Bioceutical, to explore the full therapeutic potential of cannabinoid molecules, like cannabidiol (CBD).
dsm-firmenich Resources (1)
-
News CPHI Frankfurt 2022: Innovator Interview – DSM Biomedical
At CPHI Frankfurt we spoke to Anne-Cecile Bayne, Global Science & Innovation Lead Pharma and Medical Nutrition, and Marc Hendriks, Vice President Strategy & Business Development, on their expertise in nitrosamines and business strategy at DSM Biomedical.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance